Evidence map›Paper›PMID 37540213›Full record

ArticleAging2023

Development of tryptophan metabolism patterns to predict prognosis and immunotherapeutic responses in hepatocellular carcinoma.

Guo Long, Dong Wang, Jianing Tang, Weifeng Tang

Abstract read
In one paragraph

Article in Aging, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Guo LongDepartment of Liver Surgery, Xiangya Hospital, Central South University, Changsha 410008, Hunan, China.
Dong WangLiver Disease Center, The Affiliated Hospital of Qingdao University, Qingdao 266000, Shandong, China.
Jianing TangDepartment of Liver Surgery, Xiangya Hospital, Central South University, Changsha 410008, Hunan, China.
Weifeng TangDepartment of Gastroenterology, The Second Hospital of Zhuzhou, Zhuzhou 412005, Hunan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tryptophan metabolism is associated with tumorigenesis and tumor immune response in various cancers. Liver is the main place where tryptophan catabolism is performed. However, the role of tryptophan metabolism in hepatocellular carcinoma (HCC) has not been well clarified. In the present study, we described the mutations of 42 tryptophan metabolism-related genes (TRPGs) in HCC cohorts. Then, HCC patients were well distributed into two subtypes based on the expression profiles of the 42 TRPGs. The clinicopathological characteristics and tumor microenvironmental landscape of the two subtypes were profiled. We also established a TRPGs scoring system and identified four hallmark TRPGs, including

Indexed as

Carcinoma, HepatocellularLiver NeoplasmsAldehyde Dehydrogenase, MitochondrialHumansImmunotherapyPrognosisTryptophanAldehyde Dehydrogenase, MitochondrialALDH2 protein, humanTryptophanhepatocellular carcinomaimmunotherapeutic responsespredicting prognosistryptophan metabolismtumor microenvironment

Identifiers

PMID37540213
PMCPMC10457071

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.